Loading viewer...
investor_presentation
Format: PDF investor_presentation
Verrica Pharmaceuticals presents company overview highlighting the FDA approval of YCANTH™, the first FDA-approved treatment for molluscum contagiosum. The presentation covers Verrica's business strategy, clinical programs, and commercial launch plans for its lead product candidate.
investor_presentation
54 Pages
investor_presentation
20 Pages
Clover Health
Swiss Military Consumer Goods Q4 FY24 Investor Presentation
investor_presentationinvestor_presentation
26 Pages
Swiss Military Consumer Goods Limited
Ratio Energies Investor Presentation August 2023
investor_presentationinvestor_presentation
16 Pages
Ratio Energies Limited Partnership